Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$239.25 - $280.76 $2.18 Million - $2.55 Million
9,100 Added 13.42%
76,900 $21.4 Million
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $800,734 - $911,132
3,400 Added 5.28%
67,800 $16.9 Million
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $7.16 Million - $8.17 Million
-31,900 Reduced 33.13%
64,400 $16.1 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $129,570 - $163,191
-700 Reduced 0.72%
96,300 $22.3 Million
Q3 2023

Nov 15, 2023

BUY
$233.08 - $265.59 $22.6 Million - $25.8 Million
97,000 New
97,000 $24.1 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.